-
Study aim
-
Evaluating the effectiveness of immersive virtual reality as an intra-operative pain management method
-
Design
-
A two-arm parallel group randomized clinical trial, non-blinded, phase 3, with a sample size of 25 patients in each group, utilizing a pool of opaque sealed envelopes for randomization.
-
Settings and conduct
-
The research will take place at Akhtar Hospital in Tehran. Patients assigned to the virtual reality group will be exposed to a tranquil virtual environment before undergoing the supraclavicular block. They will receive comprehensive explanations regarding the block procedure and reassurances that they have the option to halt the use of the virtual reality goggles at any point during the procedure if they experience any adverse effects like nausea, vomiting, or headaches. Additionally, the dosage of midazolam (0.01 mg/kg/dose) will be adjusted according to the patient's need. The experiment will utilize the Oculus Quest 2 virtual reality headset, displaying serene landscapes encompassing plains, forests, and seas, accompanied by calming music played for the patient in both the block room and operating room.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: Upper limb surgical operation indication, informed consent, age between 18 to 65 years.
Exclusion conditions: Any uncontrolled systemic disease, history of seizures, history of migraines, inner ear disorders
-
Intervention groups
-
Virtual Reality Group: Patients undergoing upper limb surgical procedures who are immersed in a calming virtual reality environment during nerve block and surgery using a virtual reality device.
Control Group: Patients undergoing upper limb surgical procedures in the usual manner for nerve block and surgery without utilizing the virtual reality device
-
Main outcome variables
-
The amount of anesthetic drugs used during the surgery